Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02795897 · ClinicalTrials.gov registry record
Genomic Translation for Amyotrophic Lateral Sclerosis Care
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 254
- Enrollment target
NCT02795897 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 254 participants.
The verdict
NCT02795897 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 254 participants
- Enrollment target
Study Summary
The purpose of this study is to look for abnormal genes and gene expression profiles that help determine why a person develops amyotrophic lateral sclerosis (ALS) and related motor neuron diseases (MND) and why their symptoms present and progress with a particular pattern.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2016-06-08 |
| Est. Completion | 2022-06-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02795897
The ClinicalTrials.gov registry entry for NCT02795897 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02795897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02795897 about?
NCT02795897 is a clinical study titled "Genomic Translation for Amyotrophic Lateral Sclerosis Care". The purpose of this study is to look for abnormal genes and gene expression profiles that help determine why a person develops amyotrophic lateral sclerosis (ALS) and related motor neuron diseases (MND) and why their symptoms present and progress with a particular pattern.
What is the current status of trial NCT02795897?
This trial is currently completed. The enrollment target is 254 participants. The study started on 2016-06-08. Estimated completion is 2022-06-29.
Who is sponsoring clinical trial NCT02795897?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.